The global next generation mass spectrometer market is poised for robust growth as pharmaceutical companies, research institutions, and diagnostic laboratories increasingly invest in advanced analytical platforms for molecular characterization, biomarker discovery, and precision diagnostics. Valued at USD 2.3 billion in 2025, the market is projected to reach USD 4.7 billion by 2035, expanding...
SPARK Website
عربي